Cimeio Therapeutics’ $50 Million Series A Financing Round

Walder Wyss advised Versant Ventures on the deal. VISCHER advised Cimeo Therapeutics.Versant Ventures announced the debut of Cimeio Therapeutics, a biotechnology company developing a novel approach…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now